Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aarash Saleh (London, United Kingdom), Aarash Saleh, Bessie Kwok, Jeremy Brown, John Hurst. Determinants and assessment of excess cardiovascular risk in bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 468

Member's Comments

No comment yet.

Related content which might interest you: Correlates and assessment of excess cardiovascular risk in bronchiectasis Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017 Year: 2017 Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Abnormal heart rate variability in patients with bronchiectasis Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Severe pulmonary sarcoidosis: definition and risk stratification Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Adipokines and ghrelin in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Functional status in high and low risk patient with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013 Symptoms of COPD in the general population are associated with overweight and obesity Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 BNP can be an all-cause mortality predictor in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Determinants of fatigue in patients with bronchial asthma Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 COPD exacerbations occur more frequently in the presence of cardiovascular and pulmonary comorbidities and increase serum lipids Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 The effect of obesity on lung function Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Factors determining the presence of osteoporosis in active and former smokers Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015